Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07651358 · ClinicalTrials.gov registry record · NA

A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

A NA study, sponsored by OHSU Knight Cancer Institute.

Recruiting
Registry status
NA
Development phase
30
Enrollment target

NCT07651358 is a NA study that is actively recruiting participants, run by OHSU Knight Cancer Institute. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07651358, a NA study, is actively recruiting participants, sponsored by OHSU Knight Cancer Institute.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

This clinical trial studies whether a tailored, web-based program (web portal), Community for Physical Activity and Supportive Nutrition Strategies (COMPASS), can be used to improve exercise and dietary changes in patients with stage I-III pancreatic cancer who are receiving chemotherapy before surgery (neoadjuvant). Pancreatic cancer is a rare and understudied cancer, particularly in the area of promoting a healthy lifestyle to preserve physical and mental well-being during a long and difficult treatment regimen. Since pancreatic cancer is rare, programs have limited resources available to reach the patients who could benefit from programs aimed at promoting exercise and a healthy diet. The COMPASS web-portal is easily accessed by the patient via a computer, tablet, or phone. It is tailored to the unique needs of pancreatic cancer patients and provides exercise and diet recommendations along with behavioral support as they undergo the long process of cancer therapy. This may be a more effective way to reach and engage with the patient, which may improve exercise and dietary changes in stage I-III pancreatic cancer patients receiving neoadjuvant chemotherapy.

Interventions

  • BEHAVIORAL Physical Activity and Nutritional Recommendations and Support

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-04-15
Est. Completion 2027-06-30
Phase NA

Sponsor

OHSU Knight Cancer Institute

211 total trials

What the Registry Record Tells You About NCT07651358

The ClinicalTrials.gov registry entry for NCT07651358 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Physical Activity and Nutritional Recommendations and Support is the first listed.

NCT07651358 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07651358 about?

NCT07651358 is a clinical study titled "A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy". This clinical trial studies whether a tailored, web-based program (web portal), Community for Physical Activity and Supportive Nutrition Strategies (COMPASS), can be used to improve exercise and dietary changes in patients with stage I-III pancreatic cancer who are receiving chemotherapy before surg...

What is the current status of trial NCT07651358?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-04-15. Estimated completion is 2027-06-30.

What interventions are being tested in trial NCT07651358?

The interventions under investigation include: Physical Activity and Nutritional Recommendations and Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT07651358?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.